Stock Alert: 89bio (ETNB) Trades 6.47% Higher June 23

Equities Staff  |

Today, 89bio Inc (NASDAQ:ETNB) rose $0.22 to close Thursday at $3.62.

The company opened at $3.40 and shares fluctuated between $3.62 and $3.35 with 240,180 shares trading hands.

89bio is averaging 350,573 shares traded over the last 30 days. They have shed 73.99% YTD.

89bio is set to release earnings on 2022-08-11.

For technical charts, analysis, and more on 89bio visit the company profile.

About 89bio Inc

89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). 89bio is headquartered in San Francisco with operations in Herzliya, Israel.

To get more information on 89bio Inc and to follow the company's latest updates, you can visit the company's profile page here: 89bio Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?

Market Movers

Sponsored Financial Content